With the analysis among 487 patents, we discovered top 227 key players by total patent application. DowElanco Ltd., Modalis Therapeutics Corp., Biocytogen Pharmaceuticals (Beijing) Co., Ltd. are dominant in this area. They take 14.58% of the total patent filing.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 14
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 13
California, United States
Patent: 11
Massachusetts, United States
Patent: 10
New York, United States
Patent: 9
New South Wales, Australia
Patent: 9
Colorado, United States
Patent: 9
China-Japan Friendship Hospital
Beijing Shi, China
Patent: 9
Hong Kong SAR, China
Patent: 9
With the analysis among 32 patents, we discovered top 15 start-ups by total patent application. Modalis Therapeutics Corp., AnchorDX Corp., Guangzhou Kangliming Biosciences Technology Co. Ltd. are active in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 14
Guangdong Sheng, China
Patent: 3
Guangzhou Kangliming Biosciences Technology Co. Ltd.
Guangdong Sheng, China
Patent: 2
California, United States
Patent: 2
Jiangsu Sheng, China
Patent: 1
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 1
Entos Pharmaceuticals, Inc.
Shanghai Realbio Technology Co. Ltd.
Shanghai Shi, China
Patent: 1
California, United States
Patent: 1
With the analysis among related 402 patents applied in the last 5 years. We discover 243 most active companies in this area. The fast-growing Modalis Therapeutics Corp., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., OncoSec Medical, Inc. take 9.45% of patent filing during this period.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 14
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 13
California, United States
Patent: 11
China-Japan Friendship Hospital
Beijing Shi, China
Patent: 9
Beijing Xianyun Qiyuan Technology Co., Ltd.
Beijing Shi, China
Patent: 9
Hong Kong SAR, China
Patent: 9
Shanghai Academy of Agricultural Science
Shanghai Shi, China
Patent: 8
Jiangsu Sheng, China
Patent: 7
South China Agricultural University
Guangdong Sheng, China
Patent: 7
Huazhong Agricultural University
Hubei Sheng, China
Patent: 7
With the analysis among related 402 patents in last 5 years, we discover 207 new entrants. Modalis Therapeutics Corp., Biocytogen Pharmaceuticals (Beijing) Co., Ltd., OncoSec Medical, Inc. are the most active new entrants in this area.
Modalis Therapeutics Corp.
Tokyo-to, Japan
Patent: 14
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 13
California, United States
Patent: 11
China-Japan Friendship Hospital
Beijing Shi, China
Patent: 9
Beijing Xianyun Qiyuan Technology Co., Ltd.
Beijing Shi, China
Patent: 9
Hong Kong SAR, China
Patent: 9
Shanghai Academy of Agricultural Science
Shanghai Shi, China
Patent: 8
Jiangsu Sheng, China
Patent: 7
Huazhong Agricultural University
Hubei Sheng, China
Patent: 7
Fudan University Cancer Hospital
Guangdong Sheng, China
Patent: 7
With the analysis among 288 patents, we discovered top 89 universities and scientific research institutions by total patent application. South China Agricultural University, Jiangnan University, Huazhong Agricultural University are dominant in this area. They take 10.42% of the total patent filing.
South China Agricultural University
Guangdong Sheng, China
Patent: 15
Jiangsu Sheng, China
Patent: 7
Huazhong Agricultural University
Hubei Sheng, China
Patent: 7
Shandong Sheng, China
Patent: 5
Zhejiang Sheng, China
Patent: 4
China Medical University (Taiwan)
Taiwan Province, China
Patent: 4
Chongqing Shi, China
Patent: 4
Jilin Sheng, China
Patent: 3
Swiss Federal Institute of Technology Zurich
ZURICH, Switzerland
Patent: 3
President & Fellows of Harvard College
Massachusetts, United States
Patent: 3